Two-miRNA serum signature discriminates invasive ductal breast carcinoma in case-control cohorts
A case-control study found that a serum miR-6838-5p/miR-195-5p model discriminated invasive ductal breast carcinoma cases from healthy or non-cancer controls, ...
